02.10.2012 • NewsAbbottlawsuitspharmaceutical industry

U.S. Judge Approves $700 Million in Abbott Depakote Fines

A federal judge on Tuesday sentenced Abbott Laboratories to pay $700 million in fines and other costs for illegal marketing of its drug Depakote, in connection with a previously announced settlement, the U.S. Justice Department said.

The pharmaceutical maker said in May it would plead guilty to a misdemeanor violation of misbranding.

Under terms announced then, Abbott agreed to pay $800 million in a civil settlement, a $700 million criminal penalty and $100 million to U.S. states to resolve consumer protection matters

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read